Douglas S. Ingram Salary and Compensation - Sarepta Therapeutics, Inc. CEO Salary 2025

In fiscal year 2025, Douglas S. Ingram, Chief Executive Officer of Sarepta Therapeutics, Inc. (SRPT), received total compensation of $7.8 million.

Douglas S. Ingram's compensation breakdown includes: base salary of $1.2 million, stock awards valued at $6.0 million, non-equity incentive compensation of $649K, and other compensation of $20K.

Compared to fiscal year 2024, Douglas S. Ingram's total compensation increased 296% from $2.0 million to $7.8 million.

Sarepta Therapeutics, Inc. (SRPT) Executive Pay 2025

Sarepta Therapeutics, Inc.'s top 6 named executive officers received combined total compensation of $26.9 million in fiscal year 2025.

The named executive officers disclosed in Sarepta Therapeutics, Inc.'s 2025 proxy statement are:Douglas S. Ingram (Chief Executive Officer) with total compensation of $7.8 million, Louise Rodino-Klapac (Ph.D.) with total compensation of $4.5 million, Ian M. Estepan (President,) with total compensation of $4.4 million, Cristin L. Rothfuss (Executive Vice President,) with total compensation of $4.2 million, Ryan H. Wong (Executive Vice President,) with total compensation of $3.2 million, and Dallan Murray (Former Executive Vice President,) with total compensation of $2.7 million.